David R. McAvoy

Insider Reports History

Entity
Individual
Location
C/O Endocyte, Inc., 3000 Kent Avenue, Suite A1 100, West Lafayette, IN
Signature
/s/ Dov Bergwerk as attorney-in-fact for David R. McAvoy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David R. McAvoy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fresh Tracks Therapeutics, Inc. Gen Counsel, CCO, & Secretary Common Stock 16.1K $15.9K $0.99 Oct 2, 2023 Direct
Fresh Tracks Therapeutics, Inc. Gen Counsel, CCO, & Secretary Common Stock 310 $307 $0.99 Oct 2, 2023 By spouse
TEVA PHARMACEUTICAL INDUSTRIES LTD EVP, Chief Legal Officer Restricted Share Units 67K Mar 4, 2024 Direct
Fresh Tracks Therapeutics, Inc. Gen Counsel, CCO, & Secretary Restricted Stock Units 0 $0.91 Oct 2, 2023 Direct

Insider Reports Filed by David R. McAvoy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2024 1 $0 4 Mar 5, 2024 EVP, Chief Legal Officer
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2024 0 $0 3 Mar 5, 2024 EVP, Chief Legal Officer
FRTX Fresh Tracks Therapeutics, Inc. Oct 2, 2023 3 -$7.21K 4 Oct 4, 2023 Gen Counsel, CCO, & Secretary
FRTX Fresh Tracks Therapeutics, Inc. Jan 24, 2023 1 $0 4 Jan 26, 2023 Gen Counsel, CCO, & Secretary
FRTX Brickell Biotech, Inc. May 5, 2022 1 $0 4 May 9, 2022 General Counsel and CCO
FRTX Brickell Biotech, Inc. Jul 23, 2021 1 $12.1K 4 Jul 27, 2021 General Counsel and CCO
FRTX Brickell Biotech, Inc. Jun 14, 2021 1 $0 4 Jun 14, 2021 General Counsel and CCO
FRTX Brickell Biotech, Inc. May 17, 2021 2 $21.3K 4 May 19, 2021 General Counsel and CCO